logo Kompas.id
EnglishImprove Coordination between BPOM and Researchers

Improve Coordination between BPOM and Researchers

Coordination between the Food and Drug Monitoring Agency (BPOM) and the Nusantara vaccine research team should also be improved.

Oleh DEONISIA ARLINTA
· 1 menit baca
Memuat data...
KOMPAS/ADITYA PUTRA PERDANA

Activity of officers at the Clinical Pathology Laboratory of Dr. Kariadi Hospital, Semarang, Central Java, Wednesday (17/2/2021).

JAKARTA, KOMPAS — While there have been ups and downs in the development of the Nusantara vaccine, its scientific basis should continue to be prioritized. The research conducted should ensure that the Covid-19 vaccine is safe, of good quality and effective. Coordination between the Food and Drug Monitoring Agency (BPOM) and the Nusantara vaccine research team should also be improved.

Chairman of the Expert Team concurrently National Covid-19 Task Force Spokesman Wiku Adisasmito said in Jakarta on Thursday (15/4/2021) that the Nusantara vaccine or dendritic vaccine was the vaccine type worked out in the United States and subject to clinical trials in Indonesia. The government supports the development of all Covid-19 vaccines, including the Nusantara vaccine, as long they fulfill relevant requirements.

banner registration
Lanjutkan baca artikel ini dan artikel lainnya dengan daftar akun Kompas.id.
Jadilah Bagian dari Jurnalisme Berkualitas Dapatkan akses tanpa batas ke seluruh artikel premium dengan berlangganan Kompas.id.
Kompas Digital Premium 12 Bulan (Hemat 40%)
Kompas Digital Premium 12 Bulan (Hemat 40%)
Rp 360.000 /Tahun
BERLANGGANAN
Akses tak terbatas Kompas.id (web & app)
Berita digital tanpa iklan pop-up
30 arsip terbaru ePaper Kompas
Artikel Opini eksklusif
Multiplatform, akses Kompas.id melalui laptop, ponsel, ataupun tablet
Hemat 40%
POPULER
Kompas Digital Premium 1 Bulan
Kompas Digital Premium 1 Bulan
Rp 50.000 /Bulan
BERLANGGANAN
atau biarkan Google mengelola langganan Anda untuk paket ini:
Akses tak terbatas Kompas.id (web & app)
Berita digital tanpa iklan pop-up
30 arsip terbaru ePaper Kompas
Artikel Opini eksklusif
Multiplatform, akses Kompas.id melalui laptop, ponsel, ataupun tablet
Kompas Digital Premium & Koran
Kompas Digital Premium & Koran
Rp 108.000 /Bulan
BERLANGGANAN
Akses tak terbatas di Kompas.id (web & app)
Berita digital tanpa iklan pop-up
30 arsip terbaru ePaper Kompas
Artikel Opini eksklusif
Multiplatform, akses Kompas.id melalui laptop, ponsel, ataupun tablet
Pengiriman koran Kompas edisi cetak ke rumah Anda
Editor: Syahnan Rangkuti
Bagikan
Memuat data..